Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Aim to prevent diagnostic errors through hospital collaboration and teamwork

Official title: Achieving Diagnostic Excellence Through Prevention and Teamwork (ADEPT)

Run by Brigham and Women's Hospital · NCT05747755 · Data updated 2026-11-12

Hospitals will share data to see how often diagnostic errors happen and test ways to work together to reduce them for hospitalized patients.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment7200 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations2 sites (San Francisco, California and 1 other locations)
StatusRecruiting
StartedNovember 14, 2023
Main results expectedSeptember 1, 2026
Study endsMarch 2027
Registry record updatedSeptember 8, 2026
Trial IDNCT05747755 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult inpatients on general medicine services at participating hospitals who died in-hospital, were transferred to ICU within 48 hours, or had a rapid response.

Probably not a fit

Patients not experiencing the specified outcomes or those not receiving care within participating hospitals may see no direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project links hospitals to measure and share diagnostic error rates, identify underlying causes, and develop collaborative approaches to reduce harms from diagnostic errors. It uses a learning health system model and rigorous adjudication to understand where errors arise and how improvements can be sustained. The program builds on the UPSIDE study within a 55-hospital HOMERuN network to define risk factors, causes, and prevalence of inpatient diagnostic errors and to test data-sharing and teamwork strategies. The ADEPT program focuses on translating findings into hospital quality-improvement efforts and resilient processes. Eligible patients are adults admitted to general medicine who experience death, ICU transfer after 48 hours, or rapid response events during hospitalization.

Why it matters

Potential benefit: If successful, patients could experience fewer diagnostic errors and related harms due to improved hospital processes and collaboration.

How similar studies have gone: Prior work with the HOMERuN network and UPSIDE has established risk factors and adjudication methods, suggesting potential for meaningful improvements.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients admitted to general medicine services at one of the participating hospitals and who either died during the hospitalization, were transferred to the ICU \>= 48 hours after admission, or had a rapid response.

Exclusion Criteria:

* Admitted for a non-medical reason
* Patients coded in the field who are moribund on arrival to the hospital

Where it's running

  • University of California San Francisco
    San Francisco, California, United States
    Recruiting
  • Brigham & Women's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Andrew Auerbach — University of California, San Francisco
  • Study coordinator: Tiffany Lee
  • Email: tiffany.lee@ucsf.edu
  • Phone: 415-476-6949

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.